Additional postdilatation using noncompliant balloons after everolimus-eluting stent implantation: Results of the PRESS trial.

ABSTRACT:

Background

There are limited data on the clinical value of routine postdilatation using noncompliant balloons after contemporary drug-eluting stent implantation.

Hypothesis

Additional postdilatation using noncompliant balloons after everolimus-eluting stent implantation could provide better clinical outcomes.

Methods

We randomly assigned 1774 patients with coronary artery disease to undergo additional high-pressure postdilatation using noncompliant balloons and moderate-pressure dilatation using stent balloons after everolimus-eluting stent implantation. The primary endpoint was a composite of death, myocardial infarction (MI), stent thrombosis, and target vessel revascularization (TVR) 2 years after randomization.

Results

The study was discontinued early owing

SUBMITTER: Park GM 

PROVIDER: S-EPMC7298980 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature